Cargando…
Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy
The antineoplastic effects of anthracyclines have been shown to rely, at least in part, on a local immune response that involves dendritic cells (DCs) and several distinct subsets of T lymphocytes. Here, we show that the administration of anthracyclines to mice bearing established neoplasms stimulat...
Autores principales: | Ma, Yuting, Yamazaki, Takahiro, Yang, Heng, Kepp, Oliver, Galluzzi, Lorenzo, Zitvogel, Laurence, Smyth, Mark J, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716758/ https://www.ncbi.nlm.nih.gov/pubmed/23894723 http://dx.doi.org/10.4161/onci.24786 |
Ejemplares similares
-
Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2014) -
Immunogenic cell death in radiation therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2013) -
An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013) -
Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer
por: Kepp, Oliver, et al.
Publicado: (2020) -
ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013)